Literature DB >> 29718220

Outcomes of Endoscopic Therapy for Luminal Strictures in Crohn's Disease.

Raina Shivashankar1,2, Jithinraj Edakkanambeth Varayil1,3, W Scott Harmsen4, William A Faubion1, Louis M Wong Kee Song1, David H Bruining1, Kenneth W Schroeder1, John Kisiel1, Edward V Loftus1, Nayantara Coelho Prabhu1.   

Abstract

Backgrounds: We sought to describe the outcomes of endoscopic therapy of luminal strictures in patients with Crohn's disease (CD) at a large tertiary referral center.
Methods: All patients who had undergone endoscopic dilation of CD strictures between January 1, 1990 and November 30, 2013 were identified. Demographics, disease characteristics including medication use and history of surgeries, details of endoscopic procedures, and long-term outcomes were analyzed. A successful procedure was defined as ability of the endoscope to pass through the stricture after dilation or effacement of the dilating balloon under fluoroscopy. Kaplan-Meier and Cox proportional hazards analysis were used.
Results: For this study 286 index procedures for CD-related stricture dilation were performed in 273 patients (53.8% women) with median age of 45.9 years (range, 14.9-92.2). The most common stricture locations were ileocolonic anastomosis (36.4%) and colon (13.9%). One hundred fourteen (41.8%) patients had a second dilation. The cumulative probability of need for a second dilation following the index procedure was 33.6% at 1 year (95% CI, 25.9%-38.7%), 53.9% at 3 years (45.9%-61.2%), and 60.2% at 5 years (51.4%-67.5%). Six adverse events occurred after the first procedure: 4 perforations, 1 patient with bleeding, and 1 patient with abdominal pain requiring hospitalization. A total of 82 (30%) patients required surgery for their stricture. Conclusions: In a large cohort, endoscopic stricture dilation in CD was safe and effective. About 33% of patients required a second dilation at 1 year after the initial dilation; younger age and smaller inner diameter of the index stricture predicted need for a second dilation. 10.1093/ibd/izy049_video1izy049.video15794820307001.

Entities:  

Mesh:

Year:  2018        PMID: 29718220     DOI: 10.1093/ibd/izy049

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  12 in total

Review 1.  Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn's disease.

Authors:  G Pellino; D S Keller; G M Sampietro; I Angriman; M Carvello; V Celentano; F Colombo; F Di Candido; S Laureti; G Luglio; G Poggioli; M Rottoli; S Scaringi; G Sciaudone; G Sica; L Sofo; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-03-14       Impact factor: 3.781

2.  Systematic review: medical therapy for fibrostenosing Crohn's disease.

Authors:  Cathy Lu; Brandon Baraty; Helen Lee Robertson; Alexis Filyk; Hua Shen; Tak Fung; Kerri Novak; Christopher Ma; Remo Panaccione; Jean-Paul Achkar; Sara El Ouali; David Bruining; Vipul Jairath; Brian Feagan; Florian Rieder
Journal:  Aliment Pharmacol Ther       Date:  2020-05-13       Impact factor: 8.171

3.  Endoscopic Balloon Dilation Is Cost-Effective for Crohn's Disease Strictures.

Authors:  Kate E Lee; Francesca Lim; Adam S Faye; Bo Shen; Chin Hur
Journal:  Dig Dis Sci       Date:  2022-03-15       Impact factor: 3.199

4.  Management of Crohn's stricture: medical, endoscopic and surgical therapies.

Authors:  Mohamed Saleh Ismail; Aline Charabaty
Journal:  Frontline Gastroenterol       Date:  2022-02-16

5.  Clinical outcomes of endoscopic balloon dilatation of intestinal strictures in patients with Crohn's disease.

Authors:  Ophir Winder; Naomi Fliss-Isakov; Gilad Winder; Erez Scapa; Henit Yanai; Sophie Barnes; Roy Dekel; Iris Dotan; Nitsan Maharshak
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 6.  Update of endoscopic management of Crohn's disease strictures.

Authors:  Akshay Pokala; Bo Shen
Journal:  Intest Res       Date:  2020-01-30

7.  Localization of recurrent lesions following ileocolic resection for Crohn's disease.

Authors:  Hiroki Ikeuchi; Motoi Uchino; Toshihiro Bando; Yuki Horio; Ryuichi Kuwahara; Tomohiro Minagawa; Yoshiko Goto; Kurando Kusunoki; Masataka Ikeda; Naohito Beppu; Yoshio Takesue
Journal:  BMC Surg       Date:  2021-03-20       Impact factor: 2.102

8.  Therapeutic strategies for stricturing Crohn's disease in childhood: a systematic review.

Authors:  Jonathan J Neville; Alexander Macdonald; John Fell; Muhammad Choudhry; Munther Haddad
Journal:  Pediatr Surg Int       Date:  2021-01-25       Impact factor: 1.827

9.  Predictors of necessity for endoscopic balloon dilatation in patients with Crohn's disease-related small bowel stenosis.

Authors:  Yukie Hayashi; Kaoru Takabayashi; Naoki Hosoe; Hiroki Kiyohara; Satoshi Kinoshita; Kosaku Nanki; Kayoko Fukuhara; Yohei Mikami; Tomohisa Sujino; Makoto Mutaguchi; Takaaki Kawaguchi; Motohiko Kato; Haruhiko Ogata; Takanori Kanai
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

Review 10.  Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy.

Authors:  Yifei Wang; Bin Huang; Tao Jin; Dickson Kofi Wiredu Ocansey; Jiajia Jiang; Fei Mao
Journal:  Front Immunol       Date:  2022-03-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.